摘要
目的:评价百令胶囊治疗慢性肾衰的有效性。方法:检索的中文数据库包括中国知网、中国期刊全文数据库、中国学位论文全文数据库和万方数据库;维普数据库;检索的外文数据库为Cochrane图书馆、Medline(EBSCO)和Pub Med。按Cochrane系统评价的方法评价纳入研究质量,对同质研究采用Rev Man5.2进行Meta分析。结果:检索到符合要求的文献共78篇,纳入系统评价文献17篇,患者1 570名。利用JADAD评分量表和Cochrane偏倚风险评估量表对纳入的研究进行质量评分。根据纳入RCT百令胶囊及其联合用药的情况,进行亚组分析,Meta分析结果显示,百令胶囊治疗慢性肾衰竭有效率(RR=1.22,95%CI:1.10~1.35,P<0.01),改善尿素氮(RR=-3.18,95%CI:-4.38^-1.91,P<0.01)发表偏倚方面,纳入的RCT研究均为低偏倚风险,结论:基于当前证据,使用百令胶囊治疗慢性肾衰确有疗效;但文献质量有待提高。
Objective: To evaluate the efficacy of corbrin capsule for Chronic Renal Failure. Methods: Cochrane Library, Pubmed, Chinese Biomedical Database, China Academic Journal Full-text Database of Chinese Scientific Journals and Wanfang Digital Journal Full-text Database were searched and quality of retrieved literature was evaluated according to Cochrane systematic review method. Meta- analysis of homogeneous studies was carried out using RevMan 5.2, and descriptive qualitative analysis was performed. Results: The results showed that corbrin capsule alleviated the onset of chronic renal failure (RR= 1.22, 95% CI:1.10, 1.35, P〈0.00001), reduced the level of urea (RR= -3.18, 95% CI:-4.38, -1.91, P〈0.00001).
出处
《临床药物治疗杂志》
2017年第2期37-42,共6页
Clinical Medication Journal
关键词
百令胶囊
慢性肾衰
有效性
系统评价
corbrin capsule, chronic renal failure
efficacy
systematic evaluation